PETNET to make, distribute Lillys molecular imaging agent

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

PETNET Solutions, a wholly owned subsidiary of Siemens Medical Solutions USA, has entered into a commercial agreement with Eli Lilly that grants Siemens PETNET the right to manufacture and distribute Lilly’s molecular imaging agent that is currently under review by the FDA for PET imaging.

The Knoxville, Tenn.-based PETNET is the first company to sign an agreement for the commercial manufacturing and distribution of Lilly’s molecular imaging agent in the U.S., should it be FDA approved. Additionally, should Lilly’s molecular imaging agent be approved in markets outside the U.S., the companies said they would consider expanding this commercial agreement to those markets as well.